NP

Nandita Pal

Active Director Director DIN 08828865
DIN 08828865 First appointment Sep 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2020
Shareholding value •••• Premium profile

About Nandita Pal

Data last updated:

Nandita Pal is a Director at Bethel Medipharma Private Limited (since 2020). The company operates in Pharma. Bethel Medipharma Private Limited reported revenue of ₹95.6 Lakh (FY 2024).

DIN 08828865
Primary Designation Director
Industry Pharma
First Appointment 03 Sep 2020
Oldest Company Age 6 yrs
Largest company Bethel Medipharma Private Limited · ₹95.6 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bethel Medipharma Private Limited U24290WB2020PTC239412
Director03 Sep 20202020₹95.6 Lakh (FY 2024)Active

Board colleagues of Nandita Pal

Directorship timeline

Open interactive timeline →
Bethel Medipharma Private Limited
Premium access

Shareholding and investment profile for Nandita Pal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nandita Pal

Nandita Pal currently holds 1 directorship: Bethel Medipharma Private Limited (Director, since 03 Sep 2020, revenue ₹95.6 Lakh (FY 2024)).

Nandita Pal was first appointed on 03 Sep 2020 as Director at Bethel Medipharma Private Limited.

The current boards of Nandita Pal's companies include Himangshu Roy (Bethel Medipharma Private Limited), Sayantani Dey Sarkar (Bethel Medipharma Private Limited), Tapas Kumar Biswas (Bethel Medipharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available